Stopping Anti-TNF Agents in Patients with Crohnʼs Disease in Remission
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Stopping Anti-TNF Agents in Patients with Crohnʼs Disease in Remission
Authors
Keywords
-
Journal
INFLAMMATORY BOWEL DISEASES
Volume 20, Issue 4, Pages 757-766
Publisher
Oxford University Press (OUP)
Online
2014-02-27
DOI
10.1097/01.mib.0000442680.47427.bf
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- 864 Close Monitoring of CRP and Fecal Calprotectin is Able to Predict Clinical Relapse in Patients With Crohn's Disease in Remission After Infliximab Withdrawal. a Sub-Analysis of the Stori Study
- (2015) Nicolas de Suray et al. GASTROENTEROLOGY
- Tu1155 Low Dose Infliximab for Prevention of Postoperative Recurrence of Crohn's Disease: Long Term Follow-up and Impact of Infliximab Trough Levels and Antibodies to Infliximab
- (2015) Dario Sorrentino et al. GASTROENTEROLOGY
- Commentary: predicting relapse in Crohn's disease patients in remission with biologics
- (2013) J. M. Andrews ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Anti-tumour necrosis factor therapy enhances mucosal healing through down-regulation of interleukin-21 expression and T helper type 17 cell infiltration in Crohn's disease
- (2013) C. Liu et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Mechanisms of Action of Anti–tumor Necrosis Factor α Agents in Crohn’s Disease
- (2013) Simon T. C. Peake et al. INFLAMMATORY BOWEL DISEASES
- When do we dare to stop biological or immunomodulatory therapy for Crohn's disease? Results of a multidisciplinary European expert panel
- (2013) Valerie Pittet et al. Journal of Crohns & Colitis
- State-of-the-art medical prevention of postoperative recurrence of Crohn's disease
- (2013) Dario Sorrentino Nature Reviews Gastroenterology & Hepatology
- Predictors of relapse in patients with ulcerative colitis in remission after one-year of infliximab therapy
- (2013) Klaudia Farkas et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- Normalization of mucosal cytokine gene expression levels predicts long-term remission after discontinuation of anti-TNF therapy in Crohn's disease
- (2013) Renathe Rismo et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- The great debate: stopping immunomodulators and biologics in Crohn’s disease patients in remission
- (2013) Jana G Hashash et al. Expert Review of Gastroenterology & Hepatology
- Comprehensive review: antitumor necrosis factor agents in inflammatory bowel disease and factors implicated in treatment response
- (2013) Gary R. Lichtenstein Therapeutic Advances in Gastroenterology
- Predictors of relapse in patients with Crohn's disease in remission after 1 year of biological therapy
- (2012) T. Molnár et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Therapeutic Drug Monitoring of Tumor Necrosis Factor Antagonists in Inflammatory Bowel Disease
- (2012) Ingrid Ordás et al. Clinical Gastroenterology and Hepatology
- Anti-TNF Monoclonal Antibodies in Inflammatory Bowel Disease: Pharmacokinetics-Based Dosing Paradigms
- (2012) I Ordás et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Stopping infliximab in crohnʼs disease: Still an ongoing STORI
- (2012) Laurent Peyrin-Biroulet et al. INFLAMMATORY BOWEL DISEASES
- Response to biologic therapy in Crohnʼs disease is improved with early treatment: An analysis of health claims data
- (2012) David T. Rubin et al. INFLAMMATORY BOWEL DISEASES
- Phases of disease improvement unrelated to relapses
- (2012) Oluf Andersen Nature Reviews Neurology
- Outcome after discontinuation of infliximab in patients with inflammatory bowel disease in clinical remission: an observational Danish single center study
- (2012) Casper Steenholdt et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- Review article: infliximab for Crohn’s disease treatment - shifting therapeutic strategies after 10 years of clinical experience
- (2011) S. Danese et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- American College of Rheumatology/European League Against Rheumatism Provisional Definition of Remission in Rheumatoid Arthritis for Clinical Trials
- (2011) D. T. Felson et al. ANNALS OF THE RHEUMATIC DISEASES
- American College of Rheumatology/European League Against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials
- (2011) David T. Felson et al. ARTHRITIS AND RHEUMATISM
- Maintenance of Remission Among Patients With Crohn's Disease on Antimetabolite Therapy After Infliximab Therapy Is Stopped
- (2011) Edouard Louis et al. GASTROENTEROLOGY
- Stopping immunomodulators and biologics in inflammatory bowel disease patients in remission
- (2011) Kofi Clarke et al. INFLAMMATORY BOWEL DISEASES
- Maintenance of clinical benefit in Crohn’s disease patients after discontinuation of infliximab: long-term follow-up of a single centre cohort
- (2010) A. W. G. Waugh et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Regulatory T cells control the transition from acute into chronic inflammation in glucose-6-phosphate isomerase-induced arthritis
- (2010) O. Frey et al. ANNALS OF THE RHEUMATIC DISEASES
- Generation and characterisation of therapeutic tolerogenic dendritic cells for rheumatoid arthritis
- (2010) R. A. Harry et al. ANNALS OF THE RHEUMATIC DISEASES
- Low-Dose Maintenance Therapy With Infliximab Prevents Postsurgical Recurrence of Crohn's Disease
- (2010) Dario Sorrentino et al. Clinical Gastroenterology and Hepatology
- Peripheral regulatory T cells and serum transforming growth factor-β: Relationship with clinical response to infliximab in Crohnʼs disease
- (2010) Antonio Di Sabatino et al. INFLAMMATORY BOWEL DISEASES
- Development of the Crohnʼs disease digestive damage score, the Lémann score
- (2010) Benjamin Pariente et al. INFLAMMATORY BOWEL DISEASES
- Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease
- (2010) Jean Frédéric Colombel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cut-off levels and diagnostic accuracy of infliximab trough levels and anti-infliximab antibodies in Crohn's disease
- (2010) Casper Steenholdt et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- Diagnosis and assessment of Crohn’s disease: the present and the future
- (2010) Gianluca Benevento et al. Expert Review of Gastroenterology & Hepatology
- Loss of Response and Requirement of Infliximab Dose Intensification in Crohn's Disease: A Review
- (2009) Javier P Gisbert et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Heme Oxygenase-1 Protects Against Steatohepatitis in Both Cultured Hepatocytes and Mice
- (2009) Jun Yu et al. GASTROENTEROLOGY
- Mucosal Healing Predicts Sustained Clinical Remission in Patients With Early-Stage Crohn's Disease
- (2009) Filip Baert et al. GASTROENTEROLOGY
- Regulatory T Cells Reinforce Intestinal Homeostasis
- (2009) Michael J. Barnes et al. IMMUNITY
- Incidence and clinical significance of immunogenicity to infliximab in Crohnʼs disease
- (2009) Andrea Cassinotti et al. INFLAMMATORY BOWEL DISEASES
- Sustained effect after lowering high-dose infliximab in patients with rheumatoid arthritis: a prospective dose titration study
- (2008) B J F van den Bemt et al. ANNALS OF THE RHEUMATIC DISEASES
- Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): A randomized, controlled trial
- (2008) ARTHRITIS AND RHEUMATISM
- Autologous bone marrow transplantation in autoimmune arthritis restores immune homeostasis through CD4+CD25+Foxp3+ regulatory T cells
- (2008) S. T. A. Roord et al. BLOOD
- Mechanisms of action of infliximab in inflammatory bowel disease: an anti-inflammatory multitasker
- (2008) S. Danese DIGESTIVE AND LIVER DISEASE
- Step-Up and Top-Down Approaches to the Treatment of Crohn's Disease: Early May Already Be Too Late
- (2008) Laurent Peyrin-Biroulet et al. GASTROENTEROLOGY
- Long-term outcome of treatment with infliximab in 614 patients with Crohn's disease: results from a single-centre cohort
- (2008) F Schnitzler et al. GUT
- Early combined immunosuppression or conventional management in patients with newly diagnosed Crohn's disease: an open randomised trial
- (2008) Geert D'Haens et al. LANCET
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More